Cost-effectiveness of screening for microalbuminuria among African Americans

Journal of the American Society of Nephrology

Volumn 23, Issue 12, 2012, Pages 2035-2041

  Hoerger, Thomas J ^a   Wittenborn, John S ^b   Zhuo, Xiaohui ^c   Pavkov, Meda E ^c   Burrows, Nilka R ^c   Eggers, Paul ^d   Jordan, Regina ^c   Saydah, Sharon ^c   Williams, Desmond E ^c  

^a RTI INTERNATIONAL   (United States)

^b University of Chicago   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AFRICAN AMERICAN; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE HEALTH POLICY MODEL; COST EFFECTIVENESS ANALYSIS; GLOMERULUS FILTRATION RATE; HEALTH CARE POLICY; HUMAN; KIDNEY FAILURE; MICROALBUMINURIA; MODEL; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR;

EID: 84870491153     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012040347     Document Type: Article

References (20)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007 (Pubitemid 350074801)
2. US Renal Data System (USRDS): USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011
3. National Kidney Foundation: Guideline 5: Assessment of proteinuria. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39: S5-S266, 2002
4. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR: Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 290: 3101-3114, 2003 (Pubitemid 37548116)
5. Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA: A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol Dial Transplant 23: 1216-1223, 2008 (Pubitemid 351767535)
6. Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative: A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis 55: 452-462, 2010
7. Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Paykov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative: A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis 55: 463-473, 2010
8. Centers for Disease Control and Prevention: National Chronic Kidney Disease Fact Sheet: General Information and National Estimates on Chronic Kidney Disease in the United States, 2010, Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2010
9. Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13: 1338-1349, 2002 (Pubitemid 34441415)
10. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997 (Pubitemid 27252762)
11. Hsu CY, Lin F, Vittinghoff E, Shlipak MG: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14: 2902-2907, 2003 (Pubitemid 37305653)
12. US Renal Data System (USRDS): USRDS 2006 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006, p 208
13. Sarafidis PA, Riehle J, Bogojevic Z, Basta E, Chugh A, Bakris GL: A comparative evaluation of various methods for microalbuminuria screening. Am J Nephrol 28: 324-329, 2008
14. Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC: Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: Systematic review. BMJ 329: 828, 2004
15. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S; African American Study of Kidney Disease and Hypertension (AASK) Study Group: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 285: 2719-2728, 2001 (Pubitemid 32525368)
16. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia): Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-1863, 1997
17. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354: 359-364, 1999 (Pubitemid 29355751)
18. Smith DH, Nichols GA, Gullion CM, Johnson ES, Keith D: Predicting costs of care in chronic kidney disease: The role of comorbid conditions. Internet J Nephrol 4: 2007
19. Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-Effectiveness in Health and Medicine, New York, Oxford University Press, 1996
20. Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM: Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68: 2801-2808, 2005 (Pubitemid 43251026)